TRIOSYN
Triosyn Corp. has developed a novel technology to kill disease-causing microorganisms and to treat microbial infections. Its core technology, Triosyn(R) resin, is an iodinated polymer that interacts with and kills all microorganisms on contact, and due to a proprietary demand-release delivery mechanism provides enhanced safety to humans and the environment. The basic formulation of Triosyn(R) has been registered with the EPA and further registration of Triosyn(R) applications are in process.
TRIOSYN
Industry:
Biotechnology Health Care Medical Therapeutics
Founded:
1992-01-01
Address:
Williston, Vermont, United States
Country:
United States
Website Url:
http://www.triosyn.com
Total Employee:
11+
Status:
Active
Total Funding:
4 M USD
Technology used in webpage:
Nginx
Similar Organizations
Opsonix
Opsonix is a developer of a pathogen-extracting therapy designed to transform the treatment of bloodstream infections and sepsis.
Investors List
SL Ventures
SL Ventures investment in Venture Round - Triosyn
BDC Venture Capital
BDC Venture Capital investment in Venture Round - Triosyn
Innovatech Grand Montreal
Innovatech Grand Montreal investment in Venture Round - Triosyn
CDP Capital Technology Ventures
CDP Capital Technology Ventures investment in Venture Round - Triosyn
